Latest Share Chat

Hikma Pharmaceuticals Appoints Ex-US Industry Body Chief To Board

Mon, 22nd Feb 2016 09:58

LONDON (Alliance News) - Drug company Hikma Pharmaceuticals PLC on Monday said it has appointed John Castellani as an independent non-executive director.

Castellani will join on March 1 and is the former president and chief executive of Pharmaceutical Research & Manufacturers of America, a US pharmaceutical industry trade body.

Hikma shares were up 3.0% to 1,929.00 pence on Monday.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Related Shares

More News

17 Jun 2024 15:49

London close: Stocks mixed ahead of key UK inflation data

(Sharecast News) - London stocks ended Monday with a mixed performance as renewed concerns over French political uncertainty weighed on investors' min...

17 Jun 2024 09:14

Hikma adds scale to US injectables business with Xellia acquisition

(Alliance News) - Hikma Pharmaceuticals PLC on Monday bolstered its US and injectables business with the purchase of assets from Denmark's Xellia Phar...

17 Jun 2024 07:48

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Ba...

17 Jun 2024 07:42

Hikma boosts injectables business with Xellia assets acquisition

(Sharecast News) - Hikma Pharmaceuticals said on Monday that it has agreed to buy parts of Xellia Pharmaceuticals, a Copenhagen-based specialty compan...

11 Jun 2024 09:57

LONDON BROKER RATINGS: Morgan Stanley cuts Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: